Bit Capital Gmb H Cabaletta Bio, Inc. Transaction History
Bit Capital Gmb H
- $1.26 Trillion
- Q4 2024
A detailed history of Bit Capital Gmb H transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Bit Capital Gmb H holds 190,000 shares of CABA stock, worth $454,100. This represents 0.03% of its overall portfolio holdings.
Number of Shares
190,000Holding current value
$454,100% of portfolio
0.03%Shares
3 transactions
Others Institutions Holding CABA
# of Institutions
123Shares Held
44.8MCall Options Held
202KPut Options Held
110K-
Black Rock Inc. New York, NY4.76MShares$11.4 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY4.12MShares$9.85 Million0.1% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.67MShares$8.78 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$7.26 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$6.85 Million0.0% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $69.3M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...